Farah Nabil, and Mohammed Saleem. “First-Line FOLFIRINOX Vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort”. Middle Eastern Cancer and Oncology Journal, vol. 2, no. 2, Apr. 2026, pp. 11-17, https://doi.org/10.61706/MECOJ160191.